Thermo Fisher Scientific Specialty Diagnostics revenue
Specialty Diagnostics revenue at Thermo Fisher Scientific came to $1.1B for the quarter to 26 Sep 2026, down 6.5% from a year earlier.
As Thermo Fisher Scientific reported it in its earnings release and quarterly or annual report, compiled and checked by AapWire. Latest figure filed 30 Oct 2026.
By quarter
| Period ending | Specialty Diagnostics revenue | Change on a year | Filed |
|---|---|---|---|
| 26 Sep 2026 | $1.1B | down 6.5% | 30 Oct 2026 |
| 27 Jun 2026 | $1.2B | up 6.3% | 31 Jul 2026 |
| 28 Mar 2026 | $1.1B | down 0.5% | 1 May 2026 |
| 31 Dec 2025 | $1.2B | up 5.4% | 26 Feb 2026 |
| 27 Sep 2025 | $1.2B | up 4.0% | 31 Oct 2025 |
| 28 Jun 2025 | $1.1B | up 1.5% | 1 Aug 2025 |
| 29 Mar 2025 | $1.1B | up 3.5% | 2 May 2025 |
| 31 Dec 2024 | $1.2B | up 4.7% | 20 Feb 2025 |
| 28 Sep 2024 | $1.1B | up 4.2% | 1 Nov 2024 |
| 29 Jun 2024 | $1.1B | up 0.7% | 2 Aug 2024 |
| 30 Mar 2024 | $1.1B | up 0.1% | 3 May 2024 |
| 31 Dec 2023 | $1.1B | down 0.9% | 22 Feb 2024 |
| 30 Sep 2023 | $1.1B | up 1.7% | 3 Nov 2023 |
| 1 Jul 2023 | $1.1B | up 0.7% | 4 Aug 2023 |
| 1 Apr 2023 | $1.1B | down 25.2% | 5 May 2023 |
| 31 Dec 2022 | $1.1B | down 22.9% | 23 Feb 2023 |
| 1 Oct 2022 | $1.1B | down 21.8% | 4 Nov 2022 |
| 2 Jul 2022 | $1.1B | down 10.9% | 5 Aug 2022 |
| 2 Apr 2022 | $1.5B | down 8.2% | 6 May 2022 |
| 31 Dec 2021 | $1.4B | down 26.4% | 24 Feb 2022 |
| 2 Oct 2021 | $1.4B | down 4.8% | 4 Nov 2021 |
| 3 Jul 2021 | $1.2B | up 25.0% | 6 Aug 2021 |
| 3 Apr 2021 | $1.6B | up 68.6% | 7 May 2021 |
| 31 Dec 2020 | $2.0B | up 109.5% | 25 Feb 2021 |
| 26 Sep 2020 | $1.4B | up 62.7% | 30 Oct 2020 |
| 27 Jun 2020 | $988.0M | up 4.8% | 31 Jul 2020 |
| 28 Mar 2020 | $958.0M | up 0.1% | 1 May 2020 |
| 31 Dec 2019 | $939.0M | down 1.3% | 26 Feb 2020 |
| 28 Sep 2019 | $879.0M | down 1.7% | 1 Nov 2019 |
| 29 Jun 2019 | $943.0M | up 1.2% | 2 Aug 2019 |
| 30 Mar 2019 | $957.0M | up 1.1% | 3 May 2019 |
| 31 Dec 2018 | $951.0M | — | 27 Feb 2019 |
| 29 Sep 2018 | $894.0M | up 5.9% | 2 Nov 2018 |
| 30 Jun 2018 | $932.0M | up 8.1% | 3 Aug 2018 |
| 31 Mar 2018 | $947.0M | — | 4 May 2018 |
| 30 Sep 2017 | $844.0M | — | 3 Nov 2017 |
| 1 Jul 2017 | $862.0M | — | 4 Aug 2017 |
| 30 Mar 2013 | $805.6M | up 10.1% | 3 May 2013 |
| 31 Dec 2012 | $791.8M | up 12.1% | 27 Feb 2013 |
| 29 Sep 2012 | $706.7M | up 14.8% | 2 Nov 2012 |
Definition
Revenue from this part of the business, as the company names and reports it in its results. Each figure is read from the table or sentence the company printed and kept with its scale and decimals; see data and methodology.
Other operating KPIs of Thermo Fisher Scientific: Organic revenue (change on a year) · Remaining performance obligations · Product revenues · Service revenues · Consumables revenue · Instruments revenue · Clinical research revenue · Research and safety market channel revenue · Pharma services revenue · Biosciences revenue · BioProduction revenue · Chromatography and mass spectrometry revenue · Electron microscopy revenue · Genetic sciences revenue · Laboratory products revenue · Healthcare market channel revenue · Chemical analysis revenue · Clinical diagnostics revenue · ImmunoDiagnostics revenue · Transplant diagnostics revenue · Microbiology revenue · Laboratory Products and Biopharma Services revenue · Life Sciences Solutions revenue · Analytical Instruments revenue · financial statements
Every KPI and segment of TMO, in the terminal.
Ten years of operating figures, segments, guidance against results, charts and alerts on each new release.